JTCS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Gail Darling
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Darling, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Darling, G.
Related Collections
Right arrow Lung - cancer

J Thorac Cardiovasc Surg 2008;135:718-719
© 2008 The American Association for Thoracic Surgery

Letter to the Editor

Reply to the Editor

Gail Darling, MD, FRCSC

Toronto General Hospital, Division of the University Health Network, University of Toronto, Toronto, Ontario, Canada

The first 20% of the full text of this article appears below.

Dr Van Schil's letter clearly enunciates the concern of many surgeons that the combination of chemotherapy and radiation for induction increases the risk of subsequent surgical intervention, whereas the use of induction chemotherapy alone does not. Although the report from Martin and colleagues,1Go as well as the data from the Intergroup 0139 trial,2Go support this concern, we believe this not to be the case. In our experience, as outlined in our report, the mortalities all occurred early in our experience with this protocol. There were no mortalities . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The American Association for Thoracic Surgery.